Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02259231
What this trial is testing

RTA 408 Capsules in Patients With Melanoma - REVEAL

Who this might be right for
MelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma
Biogen 41
Very early researchUnknownNCT03649529
What this trial is testing

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

Who this might be right for
Malignant Melanoma
Timmune Biotech Inc. 6
Testing effectiveness (Phase 2)UnknownNCT00287131
What this trial is testing

Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients

Who this might be right for
Metastatic Melanoma
Sheba Medical Center 70
Not applicableStudy completedNCT06079619
What this trial is testing

Comparison of Dermatoscopy X400 Interpreted by 6 Non-dermatologists and an Artificial Intelligence Software Skin Artificial Intelligence Versus Dermatoscopy x 20

Who this might be right for
Genital TumorPigmented Lesions
Centre Hospitalier Universitaire de Saint Etienne 157
Testing effectiveness (Phase 2)Study completedNCT03617328
What this trial is testing

Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 33
Testing effectiveness (Phase 2)Study completedNCT00831545
What this trial is testing

Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)

Who this might be right for
Metastases of Central Nervous SystemMelanomaBreast Neoplasm+1 more
Merck Sharp & Dohme LLC 162
Testing effectiveness (Phase 2)Study completedNCT00338130
What this trial is testing

Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Who this might be right for
Melanoma
AstraZeneca 239
Large-scale testing (Phase 3)Ended earlyNCT00796445
What this trial is testing

A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor

Who this might be right for
Melanoma
GlaxoSmithKline 1,351
Testing effectiveness (Phase 2)Ended earlyNCT03361228
What this trial is testing

Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors

Who this might be right for
Solid Tumors
Incyte Corporation 5
Testing effectiveness (Phase 2)UnknownNCT03374839
What this trial is testing

Combined Therapy of Nivolumab and Adoptive T Cell Therapy in Metastatic Melanoma Patients

Who this might be right for
Melanoma
Nantes University Hospital 11
Not applicableStudy completedNCT00025012
What this trial is testing

Isotretinoin in Preventing Skin Cancer

Who this might be right for
Melanoma (Skin)Non-melanomatous Skin Cancer
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01489423
What this trial is testing

Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 270
Early research (Phase 1)Study completedNCT00399113
What this trial is testing

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Pain Therapeutics 12
Not applicableStudy completedNCT05126173
What this trial is testing

DERM US and EU Validation Study

Who this might be right for
Malignant Skin Melanoma T0Basal Cell CarcinomaSquamous Cell Carcinoma
Skin Analytics Limited 1,111
Early research (Phase 1)UnknownNCT04142931
What this trial is testing

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

Who this might be right for
Stage IV Non-small Cell Lung CancerStage IV MelanomaTriple Negative Breast Cancer+1 more
Dr. Ronnie Shapira 30
Not applicableNot Yet RecruitingNCT07114172
What this trial is testing

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers

Who this might be right for
Melanoma (Skin Cancer)Health VolunteersPET / CT
Xijing Hospital 15
Testing effectiveness (Phase 2)WithdrawnNCT02862145
What this trial is testing

Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions

Who this might be right for
Melanoma
Mirna Therapeutics, Inc.
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Early research (Phase 1)Ended earlyNCT05571839
What this trial is testing

PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerColorectal Neoplasms+2 more
Seagen, a wholly owned subsidiary of Pfizer 41
Next Page